Kingdon Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443K | Sell |
233,332
-1
| -0% | -$2 | 0.06% | 53 |
|
|
2025
Q1 | $1.65M | Buy |
233,333
+68,766
| +42% | +$488K | 0.18% | 52 |
|
|
2024
Q4 | $3.62M | Buy |
164,567
+9,944
| +6% | +$219K | 0.52% | 48 |
|
|
2024
Q3 | $3.1M | Buy |
154,623
+500
| +0.3% | +$10K | 0.34% | 58 |
|
|
2024
Q2 | $2.68M | Buy |
154,123
+38,334
| +33% | +$667K | 0.29% | 56 |
|
|
2024
Q1 | $4.83M | Hold |
115,789
| – | – | 0.53% | 60 |
|
|
2023
Q4 | $2.91M | Buy |
115,789
+50,000
| +76% | +$1.26M | 0.36% | 47 |
|
|
2023
Q3 | $2.15M | Hold |
65,789
| – | – | 0.25% | 49 |
|
|
2023
Q2 | $3.83M | Buy |
+65,789
| New | +$3.83M | 0.36% | 46 |
|